EUVIMEDEUVIMED entdecken
Crossref

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor

Timoteo Delgado-Maldonado iD, Alonzo González-González iD, Adriana Moreno-Rodríguez iD, Guadalupe Rojas-Verde iD, Alma D Paz-Gonzalez iD, Debasish Bandyopadhyay iD, Gildardo Rivera iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Timoteo Delgado-Maldonado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Eugenol, Spike Glycoprotein, Coronavirus, Antiviral Agents. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus Disease‐2019 (COVID‐19) caused by SARS‐CoV‐2 remains a serious health concern worldwide. Inhibitors of the protein–protein interaction (iPPI) between the SARS‐CoV‐2 spike protein (S) and human Angiotensin‐Converting Enzyme‐2 (ACE2) are promising as potential antiviral agents. This study aimed to identify and evaluate novel compounds as inhibitors of the S receptor‐binding domain (RBD) and ACE2 interaction through Eugenol‐ and Structure‐Based virtual screening approaches. The hit compounds were corroborated as protein–protein interaction inhibitors using an ELISA‐based enzyme assay. Molecular docking and molecular dynamics (MD) studies of the selected compounds showed that they maintained a molecular interaction and stability (RMSD fluctuations less than 4 Å) with essential residues of the S protein. The best compound, Eu‐1 (IC 50 = 16 μM), prevented the interaction between the S protein and ACE2 receptor efficiently with an 83.7% inhibition at 50 μM. In addition, Eu‐1 had an adequate value of cytotoxicity (CC 50 > 200 μM). Therefore, Eu‐1 is a candidate compound for further SARS‐CoV‐2 preclinical experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2EugenolSpike Glycoprotein, CoronavirusAntiviral AgentsSARS-CoV-2HumansMolecular Docking SimulationProtein BindingMolecular Dynamics SimulationCOVID-19 Drug TreatmentBinding SitesCOVID-19

Stichwörter der Autor:innen

ACE2SARS‐CoV‐2molecular dockingnatural productsspike proteinviral attachment

Substanzen

Angiotensin-Converting Enzyme 2EugenolSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antiviral AgentsACE2 protein, human

Autor:innen und Institutionen

  • Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México.
  • Laboratorio de Estudios Epidemiológicos, Clínicos, Diseños Experimentales e Investigación, Facultad de Ciencias Químicas, Universidad Autónoma "Benito Juárez" de Oaxaca, Avenida Universidad S/N, Ex Hacienda Cinco Señore…
  • Instituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, México.
  • School of Integrative Biological and Chemical Sciences (SIBCS) & School of Earth, Environmental, and Marine Sciences (SEEMS), University of Texas Rio Grande Valley, Edinburg, Texas, USA.

ORCID-Profile: Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez, Guadalupe Rojas-Verde, Alma D Paz-Gonzalez, Debasish Bandyopadhyay, Gildardo Rivera

Förderung

  • Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional

Zitieren

APA

Delgado-Maldonado, T., González-González, A., Moreno-Rodríguez, A., Rojas-Verde, G., Paz-Gonzalez, A. D., Bandyopadhyay, D., & Rivera, G. (2025). In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70212

Vancouver

Delgado-Maldonado T, González-González A, Moreno-Rodríguez A, Rojas-Verde G, Paz-Gonzalez AD, Bandyopadhyay D, et al. In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70212

BibTeX
@article{DelgadoMaldonado2025,
  author = {Delgado-Maldonado, Timoteo and González-González, Alonzo and Moreno-Rodríguez, Adriana and Rojas-Verde, Guadalupe and Paz-Gonzalez, Alma D and Bandyopadhyay, Debasish and Rivera, Gildardo},
  title = {In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70212}
}
Kostenlos starten →